FAAP100
Fanconi anemia core complex-associated protein 100
Also known as: C17orf70, FLJ22175, FP100_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q0VG06
- Gene
- FAAP100
- Ensembl
- ENSG00000185504
- Chromosome
- 17
- Canonical length
- 881 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
FAAP100 is a component of the Fanconi anemia (FA; MIM 277650) core complex and is required for core complex stability and FANCD2 (see MIM 227646) monoubiquitination (Ling et al., 2007 [PubMed 17396147]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
881 residues, UniProt reviewed canonical sequence.
>Q0VG06|FAAP100
1 MAGAAPRVRY LAGFCCPLGG LAAGKPRVLC HEAEVFLSTG SELVYVYDQE GGLLTAAFRF
61 PDQVWHLELL APRRLLYALC ARRGLYCLSL DHPGRSRSTS QDDRDSEDGD QPSPVIPVDP
121 DACILPDAAL CAFTLLDSVL VTLVQGPARW KMQLFEQPCP GEDPRPGGQI GEVELSSYTP
181 PAGVPGKPAA PHFLPVLCSV SPSGSRVPHD LLGGSGGFTL EDALFGLLFG ADATLLQSPV
241 VLCGLPDGQL CCVILKALVT SRSAPGDPNA LVKILHHLEE PVIFIGALKT EPQAAEAAEN
301 FLPDEDVHCD CLVAFGHHGR MLAIKASWDE SGKLVPELRE YCLPGPVLCA ACGGGGRVYH
361 STPSDLCVVD LSRGSTPLGP EQPEEGPGGL PPMLCPASLN ICSVVSLSAS PRTHEGGTKL
421 LALSAKGRLM TCSLDLDSEM PGPARMTTES AGQKIKELLS GIGNISERVS FLKKAVDQRN
481 KALTSLNEAM NVSCALLSSG TGPRPISCTT STTWSRLQTQ DVLMATCVLE NSSSFSLDQG
541 WTLCIQVLTS SCALDLDSAC SAITYTIPVD QLGPGARREV TLPLGPGENG GLDLPVTVSC
601 TLFYSLREVV GGALAPSDSE DPFLDECPSD VLPEQEGVCL PLSRHTVDML QCLRFPGLAP
661 PHTRAPSPLG PTRDPVATFL ETCREPGSQP AGPASLRAEY LPPSVASIKV SAELLRAALK
721 DGHSGVPLCC ATLQWLLAEN AAVDVVRARA LSSIQGVAPD GANVHLIVRE VAMTDLCPAG
781 PIQAVEIQVE SSSLADICRA HHAVVGRMQT MVTEQATQGS SAPDLRVQYL RQIHANHETL
841 LREVQTLRDR LCTEDEASSC ATAQRLLQVY RQLRHPSLIL LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAAP100 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 48 nTPM
- spleen: 37 nTPM
- pancreas: 25 nTPM
- kidney: 24 nTPM
- thyroid gland: 23 nTPM
- liver: 22 nTPM
Single-cell type
- tuft cells: 23 nCPM
- proximal tubule cells: 19 nCPM
- megakaryocytes: 19 nCPM
- foveolar cells: 17 nCPM
- mucous neck cells: 17 nCPM
- parietal cells: 16 nCPM
Immune cell
- plasmacytoid DC: 3.2 nTPM
- classical monocyte: 3 nTPM
- memory B-cell: 3 nTPM
- myeloid DC: 2.9 nTPM
- intermediate monocyte: 2.8 nTPM
- gdT-cell: 2.4 nTPM
Brain region
- cerebellum: 34 nTPM
- white matter: 21 nTPM
- medulla oblongata: 20 nTPM
- thalamus: 19 nTPM
- cerebral cortex: 19 nTPM
- choroid plexus: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FAAP100.
Disease | AllUniProt
Conditions FAAP100 is implicated in, by any mechanism.
- Fanconi anemia, complementation group X (FANCX) MIM:621258
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 177 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Fanconi anemia, complementation group 10
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.35
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fanconi anemia-associated protein of 100kDa
- Fanconi anemia-associated
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAAP100 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAAP100 as an antibody target. Whether an autoantibody or antibody against FAAP100 could matter depends on whether native FAAP100 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAAP100 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAAP100 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...